![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
H Ozawa and MM Rasenick
Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago 60680.
In an attempt to resolve a unified postreceptor mechanism of action for antidepressant therapy, rats were treated with amitriptyline, desipramine or iprindole. Chronic treatment with these antidepressant drugs increased guanylylimidodiphosphate-[Gpp(NH)p-], NaF-, or forskolin-activated adenylate cyclase in synaptic membranes prepared from cerebral cortexes of treated rats. Gpp(NH)p-dependent inhibition of adenylate cyclase was unaffected. Maximal binding of the photoaffinity GTP analog azidoanilido-GTP (AAGTP) to the adenylate cyclase stimulatory (Gs alpha) and inhibitory (Gi alpha) G proteins was unaffected by antidepressant treatment. The chemical elimination of Gs (low pH treatment) eliminated all differences between control and antidepressant-treated groups. Further, nonneural tissues from rats receiving chronic antidepressants showed no changes in adenylate cyclase activity or AAGTP binding. The results of these studies suggest that chronic antidepressant administration promoted increased coupling between Gs and catalytic unit of adenylate cyclase. Thus, the molecular locus of antidepressant action may reside at the stimulatory GTP- binding protein, Gs.
This article has been cited by other articles:
|
|
 |
|
  R. J. Donati, Y. Dwivedi, R. C. Roberts, R. R. Conley, G. N. Pandey, and M. M. Rasenick Postmortem Brain Tissue of Depressed Suicides Reveals Increased Gs{alpha} Localization in Lipid Raft Domains Where It Is Less Likely to Activate Adenylyl Cyclase J. Neurosci., March 19, 2008; 28(12): 3042 - 3050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tardito, J. Perez, E. Tiraboschi, L. Musazzi, G. Racagni, and M. Popoli Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev., March 1, 2006; 58(1): 115 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Avissar, A. Matuzany-Ruban, K. Tzukert, and G. Schreiber {beta}-Arrestin-1 Levels: Reduced in Leukocytes of Patients With Depression and Elevated by Antidepressants in Rat Brain Am J Psychiatry, November 1, 2004; 161(11): 2066 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Donati, C. Thukral, and M. M. Rasenick Chronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsalpha Mol. Pharmacol., June 1, 2001; 59(6): 1426 - 1432. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Chen, K. A. Hasanat, J. M. Bebchuk, G. J. Moore, D. Glitz, and H. K. Manji Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and Antidepressants Psychosom Med, September 1, 1999; 61(5): 599 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ammer and R. Schulz Enhanced Stimulatory Adenylyl Cyclase Signaling during Opioid Dependence Is Associated with a Reduction in Palmitoylated Gsalpha Mol. Pharmacol., December 1, 1997; 52(6): 993 - 999. [Abstract] [Full Text]
|
|
|
|
|
|
M. Popoli, A. Venegoni, C. Vocaturo, L. Buffa, J. Perez, E. Smeraldi, and G. Racagni Long Term Blockade of Serotonin Reuptake Affects Synaptotagmin Phosphorylation in the Hippocampus Mol. Pharmacol., January 1, 1997; 51(1): 19 - 26. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
